NewAmsterdam Pharma Company N.V. (NAMS)
$21.58+1.51%Close
SELLCRISIS · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.5B
- Beta
- 0.09
- P/E (TTM)
- -10.22
- Short % float
- 23.60%
- Days to cover
- 9.4
- SI change
- +21.6%
- 1W
- -6.98%
- 1M
- -1.28%
- vs SPY 1W
- -8.14%
- vs SPY 1M
- -4.27%
Industry peers
FMP comparable companies · ranked by market cap
- KYMRSELLKymera Therapeutics, Inc.$9.0BBEARQ 25$109.85+2.84%
- CRNXBUYCrinetics Pharmaceuticals, Inc.$9.0BBULLQ 26$84.95+0.00%
- PRAXSELLPraxis Precision Medicines, Inc.$7.9BCRISISQ 11$283.56-1.40%
- IMVTSELLImmunovant, Inc.$6.9BCRISISQ 25$33.25+0.69%
- ACLXArcellx, Inc.$6.7B$115.07
- LGNDBUYLigand Pharmaceuticals Incorporated$6.1BRECOVERYQ 15$306.77+2.31%
- CGONSELLCG Oncology Inc.$6.1BCRISISQ 25$68.71+0.89%
- AKROAkero Therapeutics, Inc.$4.5B$54.65
- VKTXSELLViking Therapeutics, Inc.$3.4BCRISISQ 22$29.28+2.81%
- SLNOSoleno Therapeutics, Inc.$2.8B$53.01
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
